OREXO AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.43 SEK | -0.36% |
|
+1.77% | +26.39% |
| May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
| Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREXO AB | Specialty & Advanced Pharmaceuticals | +0.21% | +1.77% | +26.39% | +83.65% | -73.23% | 62.09M |  | | |
- Stock Market
- Equities
- ORX Stock
- Charts Orexo AB
- Relative Strength Chart